Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-05-21

Clinical Trial Update: The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials assessed red grape seed extract for effects on lipid profiles and oxidized LDL in hyperlipidemia; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Red Grape Seed Extract (red grape seed extract)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Hyperlipidemia | Phase 2, Phase 3 | Status: COMPLETED